|
Investor Relations
Amorfix is dedicated to building a sustainable and profitable
biotechnology company for its shareholders. If you would like to learn more about Amorfix you may request
information via
email alert for
company reports and news or directly by contacting:
Vigen Nazarian
VP, Strategic Alliances
Amorfix Life Sciences Ltd.
Phone: 416-847-6928
Email: vigen.nazarian@amorfix.com
Transfer Agents:
Olympia Trust Company
Suite 920, 120 Adelaide Street West
Toronto, Ontario M5H 1T1
Phone: 416-364-8081
Fax: 416-364-1827
|
